Voya Financial Advisors’s Anika Therapeutics ANIK Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-6,012	Closed	-$269K	–	660
2020 Q4	$269K	Buy	+6,012	New	+$228K	0.01%	544
2020 Q3	–	Sell	-6,671	Closed	-$232K	–	586
2020 Q2	$232K	Sell	6,671 -922	-12%	-$30.4K	0.01%	526
2020 Q1	$217K	Sell	7,593 -414	-5%	-$16.7K	0.01%	514
2019 Q4	$419K	Sell	8,007 -731	-8%	-$42.5K	0.02%	433
2019 Q3	$471K	Sell	8,738 -314	-3%	-$16.1K	0.03%	397
2019 Q2	$357K	Sell	9,052 -222	-2%	-$8.1K	0.02%	451
2019 Q1	$277K	Buy	9,274 +96	+1%	+$3.29K	0.02%	498
2018 Q4	$293K	Buy	9,178 +843	+10%	+$30.4K	0.02%	436
2018 Q3	$352K	Buy	8,335 +1,499	+22%	+$59.2K	0.02%	446
2018 Q2	$214K	Buy	6,836 +1,802	+36%	+$74.2K	0.01%	520
2018 Q1	$249K	Buy	5,034 +1,057	+27%	+$59.7K	0.02%	478
2017 Q4	$212K	Buy	3,977 +218	+6%	+$12.1K	0.01%	521
2017 Q3	$219K	Buy	+3,759	New	+$197K	0.01%	475